KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Cash from Investing Activities (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Cash from Investing Activities for 13 consecutive years, with -$104.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 30.54% year-over-year to -$104.8 million, compared with a TTM value of $27.9 million through Dec 2025, down 71.92%, and an annual FY2025 reading of $27.9 million, down 71.92% over the prior year.
  • Cash from Investing Activities was -$104.8 million for Q4 2025 at Travere Therapeutics, down from $86.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $189.2 million in Q4 2023 and bottomed at -$105.7 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is $640850.0, with a median of $6.1 million recorded in 2021.
  • Peak annual rise in Cash from Investing Activities hit 615.58% in 2023, while the deepest fall reached 822.85% in 2023.
  • Year by year, Cash from Investing Activities stood at $7.4 million in 2021, then crashed by 597.98% to -$36.7 million in 2022, then surged by 615.58% to $189.2 million in 2023, then crashed by 142.44% to -$80.3 million in 2024, then crashed by 30.54% to -$104.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for TVTX at -$104.8 million in Q4 2025, $86.6 million in Q3 2025, and $4.8 million in Q2 2025.